Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Samaneh Sepahi, Lily Kiaei, Mahmoud Kiaei & Adel Ghorani-Azam. (2023) A systematic review of emerging technologies to enhance the treatment of ovarian cancer. Pharmaceutical Development and Technology 28:7, pages 660-677.
Read now
Read now
Solmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, Muhammad Sarfraz, Yousef Fatahi, Fatemeh Atyabi & Hadi Valizadeh. (2022) Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer. Expert Opinion on Drug Delivery 19:6, pages 685-705.
Read now
Read now
Jiawen Zhao, Liang Zhang, Yingjie Qi, Kui Liao, Zhigang Wang, Ming Wen & Di Zhou. (2021) NIR Laser Responsive Nanoparticles for Ovarian Cancer Targeted Combination Therapy with Dual-Modal Imaging Guidance. International Journal of Nanomedicine 16, pages 4351-4369.
Read now
Read now
Min Fu, Wei Tang, Jing-Jing Liu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li & Rui-Jun Ju. (2020) Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. Journal of Drug Targeting 28:3, pages 245-258.
Read now
Read now
Muhammad Kashif Riaz, Xue Zhang, Ka Hong Wong, Huoji Chen, Qiang Liu, Xiaoyu Chen, Ge Zhang, Aiping Lu & Zhijun Yang. (2019) Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy. International Journal of Nanomedicine 14, pages 2879-2902.
Read now
Read now
Mesha Saeed, Sara Zalba, Ann L B Seynhaeve, Reno Debets & Timo L M ten Hagen. (2019) Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response. International Journal of Nanomedicine 14, pages 2069-2089.
Read now
Read now
Jing-Jing Liu, Wei Tang, Min Fu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li & Rui-Jun Ju. (2019) Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1947-1960.
Read now
Read now
You Ke & Cheng Xiang. (2018) Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. International Journal of Nanomedicine 13, pages 8339-8354.
Read now
Read now
Articles from other publishers (72)
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, Shalini Gautam, Disha Marwaha, Madhu Sharma & Prabhat Ranjan Mishra. (2023) Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy. Journal of Controlled Release 363, pages 290-348.
Crossref
Crossref
Soniya Kumbham, Srinivas Ajjarapu, Balaram Ghosh & Swati Biswas. (2023) Current trends in the development of liposomes for chemotherapeutic drug delivery. Journal of Drug Delivery Science and Technology 87, pages 104854.
Crossref
Crossref
Akmal M. Asrorov, Huiyuan Wang, Meng Zhang, Yonghui Wang, Yang He, Mirkomil Sharipov, Abulimiti Yili & Yongzhuo Huang. (2023) Cell penetrating peptides: Highlighting points in cancer therapy. Drug Development Research 84:6, pages 1037-1071.
Crossref
Crossref
Balaji Maddiboyina, Ramaiah, Ramya Krishna Nakkala & Harekrishna Roy. (2023) Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications. Chemical Biology & Drug Design 102:2, pages 377-394.
Crossref
Crossref
Yuan Liu, Yiru Wang, Xue Guan, Qiong Wu, Mengjun Zhang, Ping Cui, Can Wang, Xiuwei Chen, Xianwei Meng & Tengchuang Ma. (2023) Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP. ACS Applied Materials & Interfaces 15:22, pages 26484-26495.
Crossref
Crossref
Suliman Khan, William C. Cho, Arif Hussain, Sadaf Azimi, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Zehra Edis, Mesha Saeed, Timo L.M. ten Hagen, Hosein Ahmadi, Mahsa Ale-Ebrahim, Laila Abdulmohsen Jaragh-Alhadad, Rizwan Hasan Khan, Mojtaba Falahati, Xiaoju Zhang & Qian Bai. (2023) The interaction mechanism of plasma iron transport protein transferrin with nanoparticles. International Journal of Biological Macromolecules 240, pages 124441.
Crossref
Crossref
Juan Zhang, Haigang Ding, Feng Zhang, Yan Xu, Wenqing Liang & Liping Huang. (2023) New trends in diagnosing and treating ovarian cancer using nanotechnology. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Kenan Aloss & Peter Hamar. (2023) Recent Preclinical and Clinical Progress in Liposomal Doxorubicin. Pharmaceutics 15:3, pages 893.
Crossref
Crossref
Ambikesh Soni, Manohar Prasad Bhandari, Gagan Kant Tripathi, Priyavand Bundela, Pradeep Kumar Khiriya, Purnima Swarup Khare, Manoj Kumar Kashyap, Abhijit Dey, Balachandar Vellingiri, Suresh Sundaramurthy, Arisutha Suresh & José M. Pérez de la Lastra. (2023) Nano‐biotechnology in tumour and cancerous disease: A perspective review. Journal of Cellular and Molecular Medicine 27:6, pages 737-762.
Crossref
Crossref
Mehrdad Hashemi, Fatemeh Ghadyani, Sahar Hasani, Yeganeh Olyaee, Behnaz Raei, Marzieh Khodadadi, Maryam Fallah Ziyarani, Fatemeh A. Basti, Alireza Tavakolpournegari, Arash Matinahmadi, Shokooh Salimimoghadam, Amir Reza Aref, Afshin Taheriazam, Maliheh Entezari & Yavuz Nuri Ertas. (2023) Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 80, pages 104112.
Crossref
Crossref
Anindita Behera, Santwana Padhi & Amit Kumar Nayak. 2023. Design and Applications of Theranostic Nanomedicines. Design and Applications of Theranostic Nanomedicines
75
108
.
Ülo LangelÜlo Langel. 2023. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides
407
467
.
Xiaohua Li, Zhongkai Ren, Xiaohong Huang & Tengbo Yu. (2022) LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application. Cells 11:17, pages 2749.
Crossref
Crossref
Minglu Hao, Lei Zhang & Pu Chen. (2022) Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides. International Journal of Molecular Sciences 23:16, pages 9038.
Crossref
Crossref
Han Yu, Na Ning, Xi Meng, Chuda Chittasupho, Lingling Jiang & Yunqi Zhao. (2022) Sequential Drug Delivery in Targeted Cancer Therapy. Pharmaceutics 14:3, pages 573.
Crossref
Crossref
Mohamadreza Amin, Mercedeh Mansourian, Peter C. Burgers, Bahareh Amin, Mahmoud Reza Jaafari & Timo L. M. ten Hagen. (2022) Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides. Pharmaceutics 14:2, pages 458.
Crossref
Crossref
Sofia Teixeira, Maria Alice Carvalho & Elisabete M. S. Castanheira. (2022) Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review. Biomedicines 10:2, pages 486.
Crossref
Crossref
Jia Wang, Junbo Gong & Zhenping Wei. (2021) Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy. AAPS PharmSciTech 23:1.
Crossref
Crossref
Gowtham Kenguva, Ravi Bandaru, Smruti Rekha Rout, Khaled Greish, Prashant Kesharwani & Rambabu Dandela. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases
213
237
.
Sally Galal, Celine Jones & Kevin Coward. 2022. Long-Acting Drug Delivery Systems. Long-Acting Drug Delivery Systems
163
202
.
Mingyuan Li, Siyu Ma, Xiangyang Xie, Nan Liu, Zhiping Li, Zhenbo Yang, Guangyu Gao, Shiqin Li, Yuan Li, Shuangshuang Li, Xingguo Mei & Hui Zhang. (2021) Vincristine-doxorubicin co-loaded artificial low-density lipoproteins towards solid tumours. European Journal of Medicinal Chemistry 226, pages 113802.
Crossref
Crossref
Layla Al-mansoori, Philip Elsinga & Sayed K. Goda. (2021) Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy. Biomedicine & Pharmacotherapy 144, pages 112260.
Crossref
Crossref
Zhe Wang, Fenghua Meng & Zhiyuan Zhong. (2021) Emerging targeted drug delivery strategies toward ovarian cancer. Advanced Drug Delivery Reviews 178, pages 113969.
Crossref
Crossref
Jian Sheng Loh, Li Kar Stella Tan, Wai Leng Lee, Long Chiau Ming, Chee Wun How, Jhi Biau Foo, Nurolaini Kifli, Bey Hing Goh & Yong Sze Ong. (2021) Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids?. Cancers 13:21, pages 5346.
Crossref
Crossref
Monica Argenziano, Silvia Arpicco, Paola Brusa, Roberta Cavalli, Daniela Chirio, Franco Dosio, Marina Gallarate, Elena Peira, Barbara Stella & Elena Ugazio. (2021) Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research. Pharmaceutics 13:10, pages 1538.
Crossref
Crossref
Anhui Yang, Zhen Sun, Rui Liu, Xin Liu, Yue Zhang, Yulin Zhou, Ye Qiu & Xinrui Zhang. (2021) Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress. Frontiers in Oncology 11.
Crossref
Crossref
Nour AlSawaftah, William G. Pitt & Ghaleb A. Husseini. (2021) Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment. ACS Pharmacology & Translational Science 4:3, pages 1028-1049.
Crossref
Crossref
Ejaj Ahmad, Asgar Ali, Munazza Tamkeen Fatima, Nimisha, Apurva, Arun Kumar, Mamta P. Sumi, Real Sumayya Abdul Sattar, Bhawna Mahajan & Sundeep Singh Saluja. (2021) Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research 167, pages 105544.
Crossref
Crossref
Siegmund Reissmann & Margarita P. Filatova. (2021) New generation of cell‐penetrating peptides: Functionality and potential clinical application. Journal of Peptide Science 27:5.
Crossref
Crossref
Ameeduzzafar Zafar, Nabil K. Alruwaili, Syed Sarim Imam, Khalid Saad Alharbi, Muhammad Afzal, Nasser Hadal Alotaibi, Mohd Yasir, Mohammed Elmowafy & Sultan Alshehri. (2021) Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review. Journal of Drug Delivery Science and Technology 61, pages 102198.
Crossref
Crossref
Md. Habban Akhter, Sarwar Beg, Mohammed Tarique, Arshi Malik, Sarah Afaq, Hani Choudhry & Salman Hosawi. (2021) Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:2, pages 129777.
Crossref
Crossref
Swapnil Sharma, Akansha Bisht, Sanjana Tewari & Vivek Dave. 2021. Nanopharmaceutical Advanced Delivery Systems. Nanopharmaceutical Advanced Delivery Systems
379
405
.
Jafrin Jobayer Sonju, Achyut Dahal, Sitanshu S. Singh & Seetharama D. Jois. (2021) Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment. Journal of Controlled Release 329, pages 624-644.
Crossref
Crossref
Manzar Abbas, Muhammad Ovais, Sudip Mukherjee, Arbab Ali, Muhammad Hanif & Chunying Chen. 2021. Biogenic Nanoparticles for Cancer Theranostics. Biogenic Nanoparticles for Cancer Theranostics
1
26
.
Fiona Concy Rodrigues, N.G. Devi & Goutam Thakur. 2021. Advances and Challenges in Pharmaceutical Technology. Advances and Challenges in Pharmaceutical Technology
327
354
.
Laxmikant Gautam, Anamika Jain, Priya Shrivastava, Sonal Vyas & Suresh P. Vyas. 2021. Nano Drug Delivery Strategies for the Treatment of Cancers. Nano Drug Delivery Strategies for the Treatment of Cancers
1
35
.
Flavia Fontana, Raquél Bartolo & Hélder A. Santos. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy
135
162
.
Sara Aly Attia, Xiang Li, Nina Filipczak, Daniel F. Costa & Vladimir P. Torchilin. 2021. Peptide Conjugation. Peptide Conjugation
49
56
.
Nuno Vale, Diana Duarte, Sara Silva, Ana Salomé Correia, Bárbara Costa, Maria João Gouveia & Abigail Ferreira. (2020) Cell-penetrating peptides in oncologic pharmacotherapy: A review. Pharmacological Research 162, pages 105231.
Crossref
Crossref
Abimanyu Sugumaran & Vishali Mathialagan. (2020) Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer. Current Pharmaceutical Design 26:40, pages 5174-5187.
Crossref
Crossref
Yanan Li, Hailin Cong, Song Wang, Bing Yu & Youqing Shen. (2020) Liposomes modified with bio-substances for cancer treatment. Biomaterials Science 8:23, pages 6442-6468.
Crossref
Crossref
Andrzej S. Skwarecki, Michał G. Nowak & Maria J. Milewska. (2020) Synthetic strategies in construction of organic low molecular-weight carrier-drug conjugates. Bioorganic Chemistry 104, pages 104311.
Crossref
Crossref
Zehuan Liao, Siaw Wen Wong, Han Lin Yeo & Yan Zhao. (2020) Smart nanocarriers for cancer treatment: Clinical impact and safety. NanoImpact 20, pages 100253.
Crossref
Crossref
Max Sauter, Jürgen Burhenne, Walter E. Haefeli & Philipp Uhl. (2020) An Underestimated Factor: The Extent of Cross-Reactions Modifying APIs in Surface-Modified Liposomal Preparations Caused by Comprised Activated Lipids. Molecules 25:19, pages 4436.
Crossref
Crossref
Atul Jain, Teenu Sharma, Sumant Saini, Om Prakash Katare, Vandana. Soni & Bhupinder Singh. (2020) Nanocargos: A Burgeoning Quest in Cancer Management. Current Nanomedicine 10:2, pages 149-163.
Crossref
Crossref
Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Vahideh Zarrin, Sharareh Hosseinzadeh Kashani, Saied Bokaie, Masoud Najafi, Shima Tavakol, Reza Mohammadinejad, Noushin Nabavi, Chia-Ling Hsieh, Atefeh Zarepour, Ehsan Nazarzadeh Zare, Ali Zarrabi & Pooyan Makvandi. (2020) Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer. Bioengineering 7:3, pages 91.
Crossref
Crossref
Kongfang He, Jingjing Liu, Yan Gao, Yanyun Hao, Xuehua Yang & Guihua Huang. (2020) Preparation and Evaluation of Stearylamine-Bearing Pemetrexed Disodium-Loaded Cationic Liposomes In Vitro and In Vivo. AAPS PharmSciTech 21:5.
Crossref
Crossref
Balak Das Kurmi, Preeti Patel, Rishi Paliwal & Shivani Rai Paliwal. (2020) Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology. Journal of Drug Delivery Science and Technology 57, pages 101682.
Crossref
Crossref
Jiayi Pan, Sara Aly Attia, Md Abdus Subhan, Nina Filipczak, Livia Palmerston Mendes, Xiang Li, Satya Siva Kishan Yalamarty & Vladimir P. Torchilin. (2020) Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA. Molecular Pharmaceutics 17:5, pages 1638-1647.
Crossref
Crossref
Seyed Hossein Kiaie, Solmaz Mojarad-Jabali, Farnaz Khaleseh, Saeideh Allahyari, Elham Taheri, Parvin Zakeri-Milani & Hadi Valizadeh. (2020) Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives. International Journal of Pharmaceutics 581, pages 119269.
Crossref
Crossref
Hua Alexander Han, Jeremy Kah Sheng Pang & Boon-Seng Soh. (2020) Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing. Journal of Molecular Medicine 98:5, pages 615-632.
Crossref
Crossref
Kuldeep Rajpoot. (2020) Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications. Current Cancer Drug Targets 20:4, pages 271-287.
Crossref
Crossref
Alfonso Toro-Córdova, Beatriz Sanz & Gerardo F. Goya. (2020) A Concise Review of Nanomaterials for Drug Delivery and Release. Current Nanoscience 16:3, pages 399-412.
Crossref
Crossref
Samar M. Etman, Ossama Y. Abdallah, Radwa A. Mehanna & Yosra S.R. Elnaggar. (2020) Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer. International Journal of Pharmaceutics 578, pages 119097.
Crossref
Crossref
Liang Kong, Fu‐yi Cai, Xue‐min Yao, Ming Jing, Min Fu, Jing‐jing Liu, Si‐yu He, Lu Zhang, Xin‐ze Liu, Rui‐jun Ju & Xue‐tao Li. (2020) RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply. Cancer Science 111:2, pages 621-636.
Crossref
Crossref
Jana Váňová, Alžběta Hejtmánková, Jiřina Žáčková Suchanová, Pavla Sauerová, Jitka Forstová, Marie Hubálek Kalbáčová & Hana Španielová. (2020) Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles. International Journal of Pharmaceutics 576, pages 119008.
Crossref
Crossref
Songtao Li, Hongling Zhao, Yanfang Fan, Guiqin Zhao, Ruxing Wang, Fuyu Wen, Jianping Wang, Xiaohui Wang, Yu Wang & Yang Gao. (2019) Design, synthesis, and in vitro antitumor activity of a transferrin receptor‐targeted peptide–doxorubicin conjugate. Chemical Biology & Drug Design 95:1, pages 58-65.
Crossref
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2020) Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Advanced Drug Delivery Reviews 154-155, pages 245-273.
Crossref
Crossref
Vijay Mishra, Nishika Yadav & Gaurav K. Saraogi. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
423
449
.
Anas Ahmad, Farheen Khan, Rakesh Kumar Mishra & Rehan Khan. (2019) Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting. Journal of Medicinal Chemistry 62:23, pages 10475-10496.
Crossref
Crossref
Songtao Li, Hongling Zhao, Xiaoxia Mao, Yanfang Fan, Xiujun Liang, Ruxing Wang, Lijun Xiao, Jianping Wang, Qi Liu & Guiqin Zhao. (2019) Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate. Pharmaceutical Research 36:12.
Crossref
Crossref
Okhil K. Nag & James B. Delehanty. (2019) Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery. Pharmaceutics 11:10, pages 543.
Crossref
Crossref
Zhiquan Liang, Ziwen Lu, Yafei Zhang, Dongsheng Shang, Ruyan Li, Lanlan Liu, Zhicong Zhao, Peishan Zhang, Qiong Lin, Chunlai Feng, Yibang Zhang, Peng Liu, Zhigang Tu & Hanqing Liu. (2019) Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy. Current Cancer Drug Targets 19:6, pages 449-467.
Crossref
Crossref
Anjuman A Begum, Istvan Toth & Peter M Moyle. (2019) Gastrin-releasing peptide receptor-targeted hybrid peptide/phospholipid pDNA/siRNA delivery systems. Nanomedicine 14:9, pages 1153-1171.
Crossref
Crossref
Beatriz García-Pinel, Cristina Porras-Alcalá, Alicia Ortega-Rodríguez, Francisco Sarabia, Jose Prados, Consolación Melguizo & Juan M. López-Romero. (2019) Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment. Nanomaterials 9:4, pages 638.
Crossref
Crossref
Madeline T. Olson, Quan P. Ly & Aaron M. Mohs. (2018) Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation. Molecular Imaging and Biology 21:2, pages 200-218.
Crossref
Crossref
Felista L. Tansi, Margarita P. Filatova, Dmitri O. Koroev, Olga M. Volpina, Steffi Lange, Christina Schumann, Ulf K. Teichgräber, Siegmund Reissmann & Ingrid Hilger. (2018) New generation CPPs show distinct selectivity for cancer and noncancer cells. Journal of Cellular Biochemistry 120:4, pages 6528-6541.
Crossref
Crossref
Maria Gallo, Sira Defaus & David Andreu. (2019) 1988–2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research. Archives of Biochemistry and Biophysics 661, pages 74-86.
Crossref
Crossref
Devesh Kapoor, Shailendra Bhatt, Manish Kumar, Rahul Maheshwari & Rakesh K. Tekade. 2019. Basic Fundamentals of Drug Delivery. Basic Fundamentals of Drug Delivery
307
342
.
Ülo LangelÜlo Langel. 2019. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides
409
461
.
Dinesh K. Mishra, Ruchita Shandilya & Pradyumna K. Mishra. (2018) Lipid based nanocarriers: a translational perspective. Nanomedicine: Nanotechnology, Biology and Medicine 14:7, pages 2023-2050.
Crossref
Crossref
Chun Y. Wong, Hani Al-Salami & Crispin R. Dass. (2018) Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. International Journal of Pharmaceutics 549:1-2, pages 201-217.
Crossref
Crossref